Related Experiment Videos
Head and neck malignancies associated with HIV infection
1Division of Dentistry, British Columbia Cancer Agency, Vancouver, Canada.
Oral Surgery, Oral Medicine, and Oral Pathology
|February 11, 1992
Summary
Individuals with weakened immune systems, including those with human immunodeficiency virus (HIV), face a higher risk of oral cancers like Kaposi sarcoma and non-Hodgkin lymphoma. This review covers their prevalence, features, and management in HIV patients.
Area of Science:
- Oncology
- Infectious Diseases
- Oral Medicine
Background:
- Immunosuppression significantly elevates the risk of malignancy.
- Human immunodeficiency virus (HIV) infection is a major cause of immunosuppression.
- Oral cancers are a serious concern in immunocompromised individuals.
Purpose of the Study:
- To review the prevalence of oral cancers in HIV-infected individuals.
- To describe the clinical features of these malignancies.
- To outline management strategies for oral cancers in the context of HIV.
Main Methods:
- Literature review focusing on oral cancers in HIV.
- Analysis of prevalence data.
- Synthesis of clinical presentation and management guidelines.
Main Results:
- Kaposi sarcoma and non-Hodgkin lymphoma are the most common oral cancers in HIV.
- Squamous cell carcinoma is also associated with HIV disease.
- Kaposi sarcoma is particularly prevalent in the head and neck region of AIDS patients.
Conclusions:
- HIV-associated immunosuppression necessitates vigilant monitoring for oral malignancies.
- Early diagnosis and appropriate management are crucial for improving outcomes.
- Understanding the specific risks and presentations of oral cancers in HIV is essential for clinicians.